Amway to Invest $12 Million in India for Store Expansion

US-based Amway plans to invest about $12 million (around ₹100 crore) in India over the next three to five years, as per PTI. The funds will be used to open new stores and improve distributor infrastructure. India is expected to become one of the company’s top three global markets, according to its President and CEO, Michael Nelson.
Expansion of Physical Presence
The upcoming stores will be set up in different parts of the country. They will be used for customer engagement, product display, and training sessions for Amway’s business owners. This is part of the company’s plan to build a stronger offline network and make its products more accessible.
Ten Years of Manufacturing in India
Amway has completed a decade of manufacturing operations in India. The company has so far invested around $140 million in local facilities and related infrastructure. It now plans to increase exports from India, using its production base to supply international markets.
Product Portfolio
Amway’s product line includes Nutrilite health supplements, along with skincare, water and air treatment systems, and home care products. The company follows regular testing and research processes to maintain product standards. Its Indian operations continue to serve both domestic and export demand across these categories.
Continued Research and Investment
In addition to the upcoming $12 million investment, Amway will continue funding research and development activities. These things are aimed at maintaining consistency in product quality and compliance. The company’s R&D work is carried out through its global and India-based teams.
Read More: Adani Group Stocks Add ₹48,550 Crore on Oct 29, 2025 as Earnings Spark Fresh Momentum!
Conclusion
Amway’s planned investment will support its store expansion, export growth, and ongoing manufacturing activities in India over the next few years.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Oct 30, 2025, 11:55 AM IST

Team Angel One
- Auto Retail Sales Rise 18% in August 2026 to Record 2.42 Million Units, Says FADA
- Top Gainers and Losers on September 7, 2026: Apollo Hospitals and L&T Rise, While Infosys Drops Over 3%
- Novartis India Share Price in Focus; Approves ₹1,250 Crore Acquisition of Minipress & Minipres Trademarks
- JLR Plans Job Cuts as UK Government Rules Out Financial Support
- Dividend and Bonus Issue This Week (September 7 – September 12, 2026): Kalyan Jewellers, IREDA and Others in Focus


